These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 9473766)
1. Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter. Bol D; Kiguchi K; Beltrán L; Rupp T; Moats S; Gimenez-Conti I; Jorcano J; DiGiovanni J Mol Carcinog; 1998 Jan; 21(1):2-12. PubMed ID: 9473766 [TBL] [Abstract][Full Text] [Related]
2. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598 [TBL] [Abstract][Full Text] [Related]
3. Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles. Xie W; Wu X; Chow LT; Chin E; Paterson AJ; Kudlow JE Cell Growth Differ; 1998 Apr; 9(4):313-25. PubMed ID: 9563851 [TBL] [Abstract][Full Text] [Related]
4. Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Xie W; Chow LT; Paterson AJ; Chin E; Kudlow JE Oncogene; 1999 Jun; 18(24):3593-607. PubMed ID: 10380881 [TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. DiGiovanni J; Bol DK; Wilker E; Beltrán L; Carbajal S; Moats S; Ramirez A; Jorcano J; Kiguchi K Cancer Res; 2000 Mar; 60(6):1561-70. PubMed ID: 10749124 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Bol DK; Kiguchi K; Gimenez-Conti I; Rupp T; DiGiovanni J Oncogene; 1997 Apr; 14(14):1725-34. PubMed ID: 9135074 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892 [TBL] [Abstract][Full Text] [Related]
8. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Larcher F; Murillas R; Bolontrade M; Conti CJ; Jorcano JL Oncogene; 1998 Jul; 17(3):303-11. PubMed ID: 9690512 [TBL] [Abstract][Full Text] [Related]
9. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis. Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312 [TBL] [Abstract][Full Text] [Related]
10. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Dominey AM; Wang XJ; King LE; Nanney LB; Gagne TA; Sellheyer K; Bundman DS; Longley MA; Rothnagel JA; Greenhalgh DA Cell Growth Differ; 1993 Dec; 4(12):1071-82. PubMed ID: 8117621 [TBL] [Abstract][Full Text] [Related]
11. Toxicology and Carcinogenesis Studies of 4-Vinyl-1-cyclohexene Diepoxide (CAS No. 106-87-6) in F344/N Rats and B6C3F1 Mice (Dermal Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1989 Nov; 362():1-249. PubMed ID: 12695779 [TBL] [Abstract][Full Text] [Related]
12. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin. Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX Oncogene; 2006 Jan; 25(2):207-17. PubMed ID: 16170355 [TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid receptor functions as a potent suppressor of mouse skin carcinogenesis. Budunova IV; Kowalczyk D; Pérez P; Yao YJ; Jorcano JL; Slaga TJ Oncogene; 2003 May; 22(21):3279-87. PubMed ID: 12761498 [TBL] [Abstract][Full Text] [Related]
14. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis. Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944 [TBL] [Abstract][Full Text] [Related]
15. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Arbeit JM; Riley RR; Huey B; Porter C; Kelloff G; Lubet R; Ward JM; Pinkel D Cancer Res; 1999 Aug; 59(15):3610-20. PubMed ID: 10446971 [TBL] [Abstract][Full Text] [Related]
16. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy. Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154 [TBL] [Abstract][Full Text] [Related]
17. Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis. Matsumoto T; Jiang J; Kiguchi K; Ruffino L; Carbajal S; Beltrán L; Bol DK; Rosenberg MP; DiGiovanni J Cancer Res; 2003 Aug; 63(16):4819-28. PubMed ID: 12941801 [TBL] [Abstract][Full Text] [Related]
18. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas. Wang XJ; Greenhalgh DA; Lu XR; Bickenbach JR; Roop DR Oncogene; 1995 Jan; 10(2):279-89. PubMed ID: 7530825 [TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
20. An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis. Kim E; Rundhaug JE; Benavides F; Yang P; Newman RA; Fischer SM Oncogene; 2005 Feb; 24(7):1174-87. PubMed ID: 15558016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]